Enwave Corporation Stock
€0.23
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -3.360% | -4.167% | 2.679% | 69.118% | -2.542% | -18.004% | -72.189% |
| Resverlogix Corp | -3.510% | 1.852% | -17.910% | 80.328% | 3.774% | -37.143% | -90.351% |
| Aurinia Pharmaceuticals Inc. | -0.870% | -0.535% | -2.508% | 57.208% | -3.341% | 85.682% | 18.796% |
| Spectral Medical Inc | - | -3.977% | 5.625% | 138.701% | 6.289% | 230.078% | 203.957% |
News
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

